AFTER MECHANICAL WOUNDING to the stratified epidermis occurs, both keratinocyte migration and cellular proliferation, followed by differentiation, are necessary to repopulate the wound bed and restore epidermal barrier function (43) . For these events to occur, keratinocytes must be activated, that is, undergo a transition from a relatively sedentary and metabolically inactive cell type to a migratory and mitotically active phenotype (23) . Keratinocyte activation is complex and involves the spatiotemporal modulation of a vast array of structural and regulatory proteins and signaling molecules (see review, Ref. 13 ). Previously, it has been reported that changes in fatty acid metabolism and prostaglandin production can modulate keratinocyte proliferation (37, 38, 58) . Thus regulation of prostaglandin synthesis may be an important factor in the wound healing response (39, 58) . The object of this study is to examine prostaglandin biosynthesis and mechanism(s) involved in the regulation of prostaglandin production in keratinocytes in an in vitro wounding model. This model is intended as a tool to dissect the importance of prostaglandin production in the regulated epithelial wound healing response.
Prostaglandins are produced by the sequential release of arachidonic acid (AA) from membrane phospholipids by cellular phospholipases, followed by the enzymatic peroxidation and cyclooxygenation by PGH synthases, also known as cyclooxygenases (COXs). In human epidermis, AA release can occur via action of phospholipase A 2 s (PLA 2 ) (2, 22) or indirectly through the action of phospholipase C or D by the sequential hydrolysis of diacylglycerol (DAG) by DAG lipase and monoacylglyceride lipase (7) . Mammalian tissues and cells generally contain more than one PLA 2 enzyme and a growing superfamily has now been identified and categorized (see review, Ref. 16 ). Several types of PLA 2 s have been associated with fatty acid release, including an 85-kDa Ca 2ϩ -dependent cytosolic PLA 2 (cPLA 2 ) and several subtypes of secretory PLA 2 s (sPLA 2 ). cPLA 2 , also called type IV PLA 2 , is considered to be ubiquitously expressed and has distinct substrate preference for sn 2 -AA-containing phosphatidylcholine, indicating its critical role in further eicosanoid synthesis (see review, Ref. 33) . Modulation of cPLA 2 activity is tightly regulated by postreceptor signal-transduction pathways linking its activity to rapid, yet transient, fatty acid release. Overexpression of human cPLA 2 protein in HEL-30 cells, a murine keratinocyte cell line, was shown to enhance AA release, PGE 2 production, and proliferation capacity (37) . sPLA 2 s are low-molecular-weight (ϳ14 kDa) proteins that are found both extracellularly and on cellular membranes. They require millimolar Ca 2ϩ levels for catalytic activity and have a broad range of substrate specificity with respect to head group or sn 2 fatty acid when assayed in vitro (67). sPLA 2 s identified to date are distinguished mostly by their molecular sequence, disulfide bonds, and substrate preferences. Type I sPLA 2 is abundantly expressed in pancreas, where it functions as a digestive enzyme (48, 53) . It is also present, although in small amounts, in several nondigestive tissues (48, 53) . Type IIA sPLA 2 has been detected in spleen, liver, thymus, and intestine as well as several inflammatory cells, including macrophages and mast cells (see review, Ref. 48) . It is also prominent in sites of active inflammation such as the synovial fluid from rheumatoid arthritis patients (65) . Therefore, type IIA sPLA 2 is thought to play a significant role in inflammatory responses, host defense, and proliferation. Thus it is interesting that transgenic mice expressing human type IIA sPLA 2 exhibited chronic epidermal hyperplasia (21) .
A recently identified subtype, type V sPLA 2 , is highly expressed in heart, placenta, and, to a lesser extent, in lung and liver (4, 12) . Type V sPLA 2 has also been shown to be involved in AA mobilization in mouse immune cells (4, 62) , a role previously assigned solely to type IIA. Recent studies have demonstrated that a functional redundancy between type IIA and type V sPLA 2 exists with respect to their fatty acid-releasing activity (50, 62) . Type X, another recently identified member of the sPLA 2 subfamily, has been identified in human immune tissues (14) . In addition to their catalytic functions, several subtypes of sPLA 2 have been shown to modulate cellular events, including eicosanoid production, cell proliferation, and cell motility via binding to a 180-kDa M-type sPLA 2 receptor (48, 53) . With this PLA 2 superfamily rapidly growing and sPLA 2 receptor-mediated pathways being further elucidated, the question of how multiple PLA 2 subtypes function and interact within a cell or tissue needs to be addressed.
PLA 2 activity has been described in human epidermis and is associated with multiple normal skin functions, including cell growth and differentiation, formation of the permeability barrier, wound repair, and bacterial host defense (8, 19, 22, 41, 44, 72) . A variety of agents that cause skin damage, including ultraviolet (UV) irradiation and chemical irritants, induce PLA 2 -mediated fatty acid release in vitro (22, 28, 29, 36, 37, 42) . Also, differences in PLA 2 activities have been reported among epidermal layers (8) and between the cytosolic and membrane fractions of mouse keratinocytes (36) , suggesting that regulated expression of multiple forms of PLA 2 s in keratinocytes may influence differentiation and barrier formation.
Keratinocytes are known to express both COX isoenzymes (COX-1 and COX-2) (64). These isoenzymes differ primarily in that COX-1 is generally considered to be constitutively expressed, whereas COX-2 expression is rapidly induced upon stimulation. Mitogens and proinflammatory stimuli have been shown to modulate gene expression, posttranscriptional regulation, and protein synthesis of COX-2 in keratinocytes (38, 46, 56, 64) . Functional coupling between PLA 2 and COX enzymes is thought to mediate agonist-induced, temporal production of prostaglandins. Several studies reported that coupled activation of cPLA 2 and COX-1 are responsible for immediate prostaglandin synthesis, whereas coordinate induction of sPLA 2 and COX-2 protein expression is involved in cytokine-induced delayed PGE 2 production (3, 5, 9, 49, 51, 66) . Other studies suggest that a functional coupling between sPLA 2 and COX-1 is responsible for early prostaglandin synthesis (60, 61); this can occur transcellularly (61) and involve the sPLA 2 receptor and activation of cPLA 2 (24) . It is notable that the nature of these cross talk pathways is cell-type dependent and requires more investigation in human keratinocytes.
Previous data from our laboratory have shown an increase in PGE 2 synthesis in human primary keratinocytes grown under nonconfluent conditions, which gradually decreased as the density of the cultures increased (55, 58) . Endogenous PGE 2 is necessary for the high mitotic activity observed during nonconfluent keratinocyte growth (58) and this effect is mediated through activation of PGE receptor subtypes EP 2 and/or EP 4 , coupled to adenylate cyclase activity (32) . Persistent high levels of exogenous PGE 2 are growthinhibitory, possibly due to downregulation of EP 2 or EP 4 receptors. These findings indicate that modulation of PGE 2 production in the activated keratinocyte is essential to the growth and migration of keratinocytes during wound healing.
In this study, we examined PGE 2 production in proliferating keratinocytes in more detail, evaluating the roles PLA 2 and COX enzymes play in the modulation of PGE 2 synthesis. Because little information exists about sPLA 2 subtypes and sPLA 2 receptor in human epidermis, we examined whether both type IIA and type V sPLA 2 , along with the M-type sPLA 2 receptor, were present in human keratinocytes. We found that similarities exist between primary human nonconfluent cultures and keratinocytes wounded in vitro. We report that a coordinate increase of both COX-2 and sPLA 2 protein expression occurs in nonconfluent keratinocyte cultures, indicating the importance of both enzymes in modulation of PGE 2 production in human keratinocytes.
METHODS
Reagents. DMEM with high glucose, L-glutamine, and without sodium pyruvate, Hanks' buffered salt solution (HBSS), PBS, and fetal bovine serum (FBS) were obtained from BioWhittaker (Walkersvillle, MD). Sterile PBS, Taq DNA polymerase, TRIzol reagent, RNase H, penicillin, and streptomycin were purchased from GIBCO BRL (Gaithersburg, MD). Collagen (Vitrogen 100) from Collagen (Palo Alto, CA) was used at 1:6 dilution with 1ϫ PBS to coat tissue culture plates (Falcon). Fatty acid-free BSA was obtained from Calbiochem (San Diego, CA). Hexane and glycerol were obtained from EM Science (Gibbstown, NJ). AA was purchased from Nu-Chek Prep (Elysian, MN). Random hexanucleotides mixture, AMV reverse transcriptase, protease inhibitors, Pefabloc SC, and leupeptin were obtained from Boehringer Mannheim (Indianapolis, IN). Reagents for protein assays and SDS-PAGE were purchased from Bio-Rad (Hercules, CA). PGE 2 ELISA reagents and deuterated fatty acids were from Cayman Chemicals (Ann Arbor, MI). Pentafluorobenzyl bromide was obtained from Pierce (Rockford, IL). Gas chromatography-HPLC grade methanol and methylene chloride were purchased from Mallinckrodt Chemical (Paris, KY). Tetramethylammonium hydroxide, N,N-dimethylacetamide (DMA), aprotinin, pepstatin A, soybean trypsin inhibitor, and most other chemicals were obtained from Sigma (St. Louis, MO) and were of highest commercial grade available. The human embryonic kidney (HEK-293) cell lines overexpressing type IIA (RAS2FB) and type V (H101D) sPLA 2 s were kind gifts from Jay A. Tischfield and Michelle V. Winstead (Indiana University).
Isolation of primary human keratinocyte and cell cultures. Primary adult human keratinocyte cultures were prepared from human epidermis removed during reductive mammoplasties and panniculectomies, as previously described (58) . Cells were plated onto collagen-coated tissue culture dishes at a density of 7.5 ϫ 10 5 cells/cm 2 (confluent) and 1.25 ϫ 10 5 cell/cm 2 (nonconfluent) and maintained in DMEM containing 5% FBS, 1.4 mM calcium chloride, penicillin (100 IU/ml), streptomycin (100 mg/ml), and 25 mM HEPES buffer, pH 7.4 (growth medium) in 95% air-5% CO 2 at 37°C for 6 days. Nonpassaged cells were used in experiments when confluent cultures were 2 days postconfluence and nonconfluent cultures were at 15-30% cell density by visual inspection. HaCaTs, a spontaneously immortalized human keratinocyte cell line (10), was grown under the same conditions, but on uncoated plastic. RAS2FB and H101D cells were plated on uncoated dishes in growth medium containing 10% FBS and 200 µg/ml hygromycin B (GIBCO BRL) and maintained under the same conditions as keratinocytes.
Wounding of primary keratinocyte cultures. Confluent cultures grown on six-well plates were thoroughly washed and then scraped with the tip of a sterile glass rod; four wounds (2 ϫ 30 mm) were made over a 96-mm 2 surface area. The cells were washed twice with medium to remove debris, and supernatants from wounded and nonwounded cultures were taken at indicated times for PGE 2 analysis.
PGE 2 measurements and determination of COX activity. Confluent and nonconfluent cultures were thoroughly washed with prewarmed medium before the incubation period. At indicated times, cultures were put on ice to stop reaction and supernatants were removed, centrifuged at 1,000 g at 4°C to pellet cellular debris, and stored at Ϫ20°C until PGE 2 determinations were performed. On thawing, the levels of PGE 2 in supernatants were determined by ELISA using specific anti-PGE 2 monoclonal antibody; the limit of detection was 30 pg/ml. COX activity was determined by incubating cultures at 37°C for 15 min with exogenous 30 µM AA, prepared in prewarmed, serum-free DMEM, before removal of supernatants for PGE 2 determination (22) .
Basal fatty acid release: derivatization and measurement of fatty acids by gas chromatography-mass spectrometry. Confluent and nonconfluent keratinocytes grown in six-well plates were washed three times with HBSS, pH 7.4, containing penicillin, streptomycin, and HEPES in the same concentrations as used in growth medium, together with 0.01% fatty acid-free BSA and incubated in 1 ml HBSS solution for 10 min at 37°C to remove endogenous free fatty acids. Cultures were then incubated with fresh HBSS for 30-60 min. Aliquots of supernatants were taken from triplicate cultures for each condition and pooled. Deuterated D8 AA and D4 linoleic acid (LA) were added to each pooled sample as internal standards. Cell cultures were washed thoroughly with ice-cold PBS and scraped into Eppendorf tubes for protein analysis. Pooled supernatants were acidified to ϳpH 3.0 with 1 N HCl and applied to conditioned Baker Bond Spec octadecyl C18 columns (J. T. Baker). The columns were then washed with H 2 O, followed by a 10% methanol wash. Samples were eluted in 100% methanol, evaporated to dryness, then derivatized using pentafluorobenzyl esterification. This procedure is a modification of one used previously (57) . Briefly, the samples were treated with 50 µl tetramethylammonium hydroxide in DMA/methanol solution and 100 µl of a 35% pentafluorobenzyl bromide in DMA for 15 min at room temperature. The reactions were evaporated to dryness and washed twice with H 2 O/methylene chloride (1:4) and resuspended in hexane. The samples were then evaluated by gas chromatography/ mass spectrometry using an HP-1 (cross-linked methyl silicone) column. Monitoring was in the negative ion mode for the fatty acid of interest. Mass spectrometric measurements of free fatty acid were not subjected to the problems of distribution or metabolism of label that occur with prelabeling of cellular lipids, and therefore reflect total released product. These products were normalized to the estimated protein amount present in each culture condition through the use of the Bio-Rad Dc Protein Assay method using known BSA standards.
Western blot analysis of cPLA 2 , sPLA 2 , COX-1, and COX-2. Confluent and nonconfluent cultures of human primary keratinocytes grown in 100-mm petri dishes were cooled at 4°C for 10 min and rinsed twice with ice-cold PBS containing the following protease and phosphatase inhibitors: 5 µg/ml leupeptin, 1 µg/ml pepstatin A, 50 µg/ml soybean trypsin inhibitor, 1 mM Pefabloc SC, and 50 µM each of sodium orthovanadate, sodium fluoride, and sodium phosphate. Gel loading buffer (1 ϫ GLB) containing 50 mM Tris · HCl, pH 6.8, 2% SDS, 10% glycerol, and the above-mentioned inhibitors was then added to each culture dish and incubated on ice for 20 min with rocking. Cells were scraped in Eppendorf tubes, sonicated, and centrifuged at 10,000 g for 10 min at 4°C to remove particulates. The soluble portion (total cell lysate) was isolated and stored at Ϫ20°C until further assessment. Supernatants from confluent and nonconfluent cultures were collected after 24 h of incubation in fresh medium and centrifuged at 4°C for 5 min at 1,000 g to remove cellular debris. Supernatants were then concentrated by ultrafiltration using Centriprep concentrators (Amicon) and diluted with 3ϫ GLB containing protease and phosphatase inhibitors and stored at Ϫ20°C. Protein amounts were estimated as previously mentioned. Equivalent protein amounts of cell lysates and supernatants were electrophoresed on 8% SDS-PAGE gels (15% for sPLA 2 detection) and transferred to nitrocellulose membranes (Amersham). The membranes were then blocked overnight at 4°C with 5% nonfat dry milk in Tris-buffered saline (TBS). For Western blotting, recommended manufacturer's procedures for using human anti-cPLA 2 antibodies (Santa Cruz) were followed with these alterations. For cPLA 2 detection, membranes were incubated with human anti-cPLA 2 antibody (1:75) followed by an incubation with rabbit anti-mouse IgG:horseradish peroxidase (Dako) at 1:1,000 dilution. To detect sPLA 2 , membranes were incubated with human antisPLA 2 (1:1,000, Cayman) and then treated with goat antirabbit IgG:horseradish peroxidase (1:1,000). To detect COX-1 and COX-2, membranes were incubated with human anti-COX-1 (1:100; Oxford) or anti-COX-2 (1:1,000, Oxford); both blots were then treated with protein A-horseradish peroxidase (1:2,000; Amersham). Visualization of proteins was done by enhanced chemiluminescence (Amersham).
Isolation of RNA and detection of type IIA sPLA 2 , type V sPLA 2 , and M-type sPLA 2 receptor by RT-PCR. Total RNA from RAS2FB, H101D, HaCaT cell cultures, and primary keratinocytes at both nonconfluent and confluent growth densities was isolated using TRIzol reagent (GIBCO BRL) following the manufacturer's protocols with two additional phenol:chloroform (1:1) extractions added before isopropanol precipitation. First-strand RT was performed using ϳ1 µg of RNA, random hexanucleotide mixture, and AMV reverse transcriptase (Boehringer Mannheim) according to the instructions of the supplier. After the RT reactions, the samples were RNase-treated using 1 unit RNase H (GIBCO BRL) per reaction at 37°C for 20 min; cDNA products were stored at Ϫ20°C until used in PCR reactions. For identification of type IIA and type V sPLA 2 , two rounds of PCR amplification were performed for 30 and 25 cycles, respectively, in a 50-µl reaction containing 1.5 mM MgCl 2 , 200 µM dNTPs, 20 mM Tris · HCl (pH 8.4), 50 mM KCl, 2.5 units Taq polymerase, and 4 µl of cDNA product. First round PCR products were diluted 1:1,000 before second round amplification reactions. For type IIA sPLA 2 , the first round forward and reverse primers were 5Ј GGCCGGGGCAGAAGTTGAGAC 3Ј and 5Ј AGGGTAGG-GAGGGAGGGTATGAGAG 3Ј. The conditions used for this PCR reaction were as follows: 94°C for 1 min, 56°C for 1 min, and 72°C for 1 min with an additional 5 min at 72°C after final cycle. Type IIA sPLA 2 nested, second round forward and reverse primers were 5Ј CTTACCATGAAGACCCTCCTACT-GTTGGCA 3Ј and 5ЈGAGGGGACTCAGCAACGAGGGGT-GCT3Ј and PCR reaction conditions were 94°C for 1 min, 56°C for 20 s, and 72°C for 30 s with an additional 5 min at 72°C after final cycle. For type V sPLA 2 , the first round forward and reverse primers were 5ЈCCAGAGATGAAAGGCCTCCTC-CCACTGGGCTTG3Ј and 5ЈGAGGCCTAGGAGCAGAGGAT-GTTGGGAA3Ј, and the reaction conditions used were identical to the first round type IIA PCR reactions. Type V sPLA 2 nested, second round forward and reverse primers were 5ЈGTTCCTGGCTTGTAGTGTGC3Ј and 5ЈGGATGTTGGGA-AAGTATTGG3Ј. The conditions were the same as those used for nested type IIA sPLA 2 primers except that the annealing temperature was lowered to 47°C. To identify the M-type sPLA 2 receptor in human keratinocytes, primers identical to those used to identify the sPLA 2 receptor in human gestational tissues were used (45) , with some modifications to the published PCR reaction conditions. Briefly, PCR amplifications in the same reaction mixture as mentioned above were done using the following conditions: 95°C for 1 min, 65°C for 1 min, and 72°C for 1 min with an additional 5 min at 72°C after final cycle. PCR products were resolved by 1.5% agarose gel electrophoresis and visualized with Gel Star (FMC BioProducts, Rockland, ME). PCR products were then subjected to restriction analysis to partially confirm their identity. Major and minor PCR product bands were excised from gels and purified using a Qiaex II agarose gel extraction kit (Qiagen) before sequencing, which was performed by the Nucleic Acid Core Facility at the University of Rochester. Sequences of PCR products from keratinocyte and overexpressing cell lines were compared with published sequences for human type IIA SPLA 2 (65), type V sPLA 2 (12), or M-type sPLA 2 receptor (1).
RESULTS
Transient increase in PGE 2 levels in wound closure in vitro. As previously reported, PGE 2 production in human primary keratinocytes is modulated by their density in cell culture (58) . Cells grown at low densities (15-30% confluence) produced 27-fold more PGE 2 than in 2-day postconfluent cultures (4.46 Ϯ 1.64 vs. 0.164 Ϯ 0.108 ng · ml Ϫ1 ·24 h Ϫ1 ; mean Ϯ SD; n ϭ 3). Elevated PGE 2 production was also observed in in vitro wound closure experiments (Fig. 1) . After wounding confluent monolayers, dramatic changes in PGE 2 levels were observed in wounded cultures compared with unwounded confluent cultures. The rise in PGE 2 levels was rapid yet transient. A significant increase in PGE 2 accumulation within the 1st h after wounding was observed. PGE 2 levels were highest at 10 h after wounding and then gradually decreased as the wound edge closed. No keratinocyte growth into the wounded area was visually observed until 2-3 h after wounding.
Although actual PGE 2 levels and degree of wound closure at 48 h varied between individual cell preparations (n ϭ 3), the pattern and time course of PGE 2 production after wounding was almost identical in each experiment.
Morphology of human primary keratinocytes grown at low densities is similar to that of activated keratinocyte on wounding edge. In morphological studies of full-thickness injury to the skin, it was observed that keratinocytes at the wound edge undergo phenotypic changes during the initial phase of wound healing (13, 52) . Migrating keratinocytes, particularly those originating from the early-differentiating compartment of wounded epidermis, are reported to adopt a polarized, elongated appearance, with some cells having ruffled edges and cytoplasmic processes. We observed similar morphological changes in keratinocytes on the wound edge in wounding experiments in vitro (data not shown). Primary human keratinocyte cultures grown at confluent and nonconfluent densities exhibit morphological differences similar to unaffected and activated keratinocytes in a wound, respectively. Keratinocytes at 2 days postconfluence are polygonal in shape, with cytoplasms appearing full of dense, filamentous material ( Fig. 2A) . In contrast, nonconfluent cultures (15-30% confluent; Fig. 2B ) grow clonally with small central areas of stratified cells and outer edges of flattened, elongated cells. These outer cells have ruffled edges and the occasional pseudopodia indicative of motility, which was confirmed by time-lapse videomicroscopy. Long processes similar in appearance to dendrites are a distinct feature of keratinocytes grown in nonconfluent cultures. We have found that the presence of these processes and the flattened, elongated morphology of keratinocytes appears concurrently with increased PGE 2 production in nonconfluent cultures. Rhodamine phalloidin immunohistochemical staining of nonconfluent cells showed dense staining for actin within these processes (data not shown). Because other epidermal cell types that form dendritic-like processes (melanocytes and Langerhans cells) are present in small amounts in primary keratinocyte cultures, we costained with melanocyte and Langerhans cell markers (Mel-5 and MHC class II antigen, respectively). We found no correlation between these markers and the processes of interest (data not shown), thus we concluded that these processes are keratinocyte-derived.
Increase in COX activity in nonconfluent human primary keratinocyte cultures. First, we examined whether COX activity was altered in nonconfluent cultures. In Fig. 3 , it is shown that nonconfluent keratinocyte cultures synthesized ϳ25-fold greater basal concentrations of PGE 2 than confluent cultures (4.28 Ϯ 0.45 vs. 0.171 Ϯ 0.040 ng · ml Ϫ1 · 15 min Ϫ1 ; mean Ϯ SD). However, this 25-fold difference in basal PGE 2 synthesis between confluent and nonconfluent keratinocytes could reflect limiting substrate due to differences in phospholipase and/or COX activity. To determine whether the increased production of PGE 2 was dependent on increased COX activity, saturating levels of exogenous AA (30 µM) were added at the beginning of the incubation. It was found that nonconfluent keratinocytes still produced ϳ12-fold greater PGE 2 than confluent keratinocytes ( Fig. 3; 18 .43 Ϯ .77 vs. 1.59 ng · ml Ϫ1 · 15 min Ϫ1 ; mean Ϯ SD). These results demonstrated that nonconfluent keratinocytes exhibit markedly increased COX activity when compared with confluent cultures.
Increased expression of COX-2 protein levels in nonconfluent human primary keratinocyte cultures. We then examined whether the increased COX activity was due to increased expression of COX-2 and/or COX-1 isoforms. In Western blotting of total cellular lysates prepared from paired nonconfluent and confluent primary keratinocyte cultures, COX-1 protein levels were detected in both confluent and nonconfluent culture conditions. It is interesting that COX-1 protein levels varied between individual skin preparations, with some having undetectable levels (Fig. 4A ) and others having substantially higher levels. In the latter case, we observed a modest increase in COX-1 levels in nonconfluent conditions (Fig. 4B) . In all individual skin samples examined, a substantial amount of COX-2 protein was detected only in nonconfluent conditions (Fig. 4) . No COX-2 protein was detected in any confluent cultures. These results indicate a distinct induction of COX-2 protein expression in nonconfluent culture conditions, with some variability in COX-1 protein levels between individuals.
Increase in fatty acid release in nonconfluent human primary keratinocyte cultures. The availability of substrate is another rate-limiting step in eicosanoid biosynthesis. Because both AA and LA are substrates in this pathway, we measured the basal levels of these fatty acids released from nonconfluent and confluent cultures over a 30-min incubation period by gas chromatography-mass spectrometry ( Table 1) . Accumulation of http://ajpcell.physiology.org/ free fatty acids in cell supernatants was maximal at 30 min, after which it was at equilibrium with fatty acid reuptake (data not shown). There was tremendous inter-individual variability in absolute concentrations of free fatty acids monitored in each experiment. However, the ratio of nonconfluent-to-confluent (NC/C) fatty acid release clearly showed that basal AA and LA levels were higher in nonconfluent cultures compared with confluent cultures with mean values of 9.7 Ϯ 7.6 and 6.8 Ϯ 3.6 for AA and LA, respectively. Most experiments showed that AA was the prevalent fatty acid released; although in one case (expt 3), the levels of LA were higher in both growth conditions. Thus these data suggest that a non-substrate-specific phospholipase activity commonly associated with sPLA 2 is likely to be involved in the increased fatty acid release in nonconfluent cultures.
Increased expression of sPLA 2 but not cPLA 2 protein levels in nonconfluent human primary keratinocyte cultures. Because AA is the predominant fatty acid released, we examined whether increased cPLA 2 protein expression contributed to increased fatty acid release in nonconfluent cultures. We performed Western blot analysis on total cellular homogenates of both confluent and nonconfluent keratinocytes to examine cPLA 2 expression (Fig. 5) . The levels of cPLA 2 in both conditions were very low but clearly detectable. Nonconfluent keratinocytes showed no increase in total cellular cPLA 2 protein compared with confluent keratinocytes, suggesting that the increase in free AA release was not due to upregulation of cPLA 2 expression. In contrast, there was a dramatic increase in sPLA 2 expression in total cellular homogenates from nonconfluent cultures compared with confluent cultures. Identical results were seen in supernatants, although the levels of sPLA 2 protein detected in supernatants were much lower. It should be noted that the sPLA 2 antibodies used in these studies can detect both type IIA sPLA 2 and type V sPLA 2 ; therefore, we cannot conclude which sPLA 2 subtypes were upregulated from this experiment.
Identification of type IIA and type V sPLA 2 subtypes in human primary keratinocyte cultures by RT-PCR.
With recent reevaluation of the role of sPLA 2 subtypes in AA metabolism, we found it important to assess which of these sPLA 2 s were present in human keratinocytes. We used RT-PCR to detect the presence of both type IIA and V sPLA 2 transcripts in nonconfluent and confluent human primary keratinocyte cultures (Fig.  6) . RNA from two HEK-293 cell lines, RAS2FB and H101D, which overexpress type IIA sPLA 2 and type V sPLA 2 , respectively, were included as positive controls. Low abundance of message necessitated two rounds of PCR with nested primers to detect products in keratinocytes. Major bands corresponding to the predicted sizes (448 bp for type IIA sPLA 2 and 380 bp for type V sPLA 2 ) were detected in nonconfluent and confluent conditions, as well as in the appropriate overexpressing cell line (Fig. 6, A and B) . Another band, designated the minor product band (ϳ280 bp), was also observed in type V sPLA 2 RT-PCR analysis. This additional band appeared in both nonconfluent and confluent keratinocyte conditions but not in overexpressing cell line. Sequencing analysis for type IIA sPLA 2 PCR product showed that the product obtained from both nonconfluent and confluent conditions are identical to the published type IIA sPLA 2 cDNA sequence (65) . Sequencing analysis of the type V sPLA 2 PCR products showed that the major PCR product (380 bp) in nonconfluent and confluent conditions are identical to the published type V sPLA 2 cDNA sequence (12) . The minor PCR product (ϳ280 bp) present in nonconfluent and confluent condi- Mean Ϯ SD 9.7 Ϯ 7.6 6.8 Ϯ 3.6
Basal release of free arachidonic acid and linoleic acid into confluent (C) and nonconfluent (NC) culture supernatants were measured over a 30-min incubation period by gas chromatography-mass spectrometry as described in METHODS, except experiment 2, in which the incubation time was 60 min with similar results. These results were normalized to milligrams of protein present in each culture condition. Each experiment represents results obtained using a different skin preparation. Ratios of NC/C were calculated for each experiment and then averaged values were expressed as means Ϯ SD.
tions also shared 98 and 99% homology with the published sequence and with the 380-bp product, except that it was missing bases 316-422, which encompass the 5Ј end of exon III as reported by Chen et al. (12) .
Identification of M-type sPLA 2 receptor in human primary keratinocyte cultures by RT-PCR. Because the M-type sPLA 2 receptor also may play a role in mediating AA metabolism and other physiological responses such as proliferation and migration, we sought to establish whether this receptor type was present in human epidermis. Using primers that identified the presence of sPLA 2 receptor in human gestational tissues (45), we performed RT-PCR on RNA obtained from nonconfluent and confluent keratinocytes, as described in METHODS, through the use of the appropriate negative controls. A band corresponding to the predicted size of 399 bp was detected in both nonconfluent and confluent conditions (Fig. 7) . The PCR product from confluent keratinocyte conditions was sequenced and found to share 99% homology with the reported human M-type SPLA 2 receptor sequence (1). In both HEKoverexpressing cell lines, no PCR product was detected (data not shown). However, a PCR product of the same size was observed in RT-PCR reactions using RNA from HaCaT cultures (data not shown), suggesting that the sPLA 2 receptor is keratinocyte-associated.
DISCUSSION
Physical separation of keratinocytes from normal skin and transfer to tissue culture constitutes an activation, or wound signal for keratinocytes (23) . In subconfluent cultures, keratinocytes tend to grow in colonies and require cell migration to sustain clonal growth (6) . On reaching confluence, the activated phenotype is lost and the cells begin to stratify and express various markers of keratinocyte differentiation (59) . In previous studies, we have shown an inverse relationship between the level of basal PGE 2 production and state of confluence in human primary keratinocyte cultures (55, 58) . In this study, we observed a similar pattern of PGE 2 synthesis in an in vitro wound model (Fig. 1) . After the wounding of confluent cultures, PGE 2 levels increased rapidly but transiently; as the wound closed and confluence was restored, the levels of PGE 2 declined. Although there was some sample variability in the actual levels of PGE 2 measured and in extent of wound closure by 48 h, the time course of change in PGE 2 levels remained consistent (n ϭ 3). This result was indicative of distinct modulation of the enzymes involved in PGE 2 synthesis after in vitro wounding, and validated the use of the nonconfluent culture system as an injury model.
Keratinocytes grown at nonconfluent densities (15-30% confluent) adopt a distinct morphology (Fig. 2) . The phenotypes of keratinocytes grown at low densities and in wounds in vitro and in vivo (52) are all strikingly similar. Moreover, these morphological similarities concur with increased PGE 2 synthesis observed in nonconfluent cultures and in in vitro wounding as reported in this study and in in vivo wounds (39) . Thus we consider the small clonal island of keratinocytes found in nonconfluent cultures to be akin to a 360°wound with outer cells analogous to the wound edge. We postulated that nonconfluent cultures are a good model in which to examine the modulation of enzymes involved in increased PGE 2 biosynthesis in activated keratinocytes. PGE 2 biosynthesis in intact cells is modulated by the level of COX proteins present, the amount of substrate available, and the level of phospholipases present. In this study, we found that in nonconfluent keratinocyte cultures, COX-2 protein expression together with nonspecific fatty acid release and sPLA 2 protein expression was increased and is most likely responsible for the increase in PGE 2 production in this culture condition. First, we established that nonconfluent cultures exhibit increased COX activity compared with confluent cultures (Fig. 3) . The addition of saturating levels of exogenous AA (30 µM) is a direct way of assessing COX activity in intact cells. Here, we observed that COX activity in nonconfluent cultures was still considerably higher, suggesting that COX protein levels are elevated Fig. 5 . Expression of cytosolic phospholipase A 2 (cPLA 2 ) and secretory PLA 2 (sPLA 2 ) in total cell lysates and supernatants obtained from confluent and nonconfluent conditions. Total cell lysates and supernatants were prepared from confluent and nonconfluent cultures as discussed in METHODS. For detection of cell-associated cPLA 2 and sPLA 2 , equivalent amounts of total cell lysates were subjected to SDS-PAGE, transferred to nitrocellulose, and probed with antibody of interest. For detecting sPLA 2 in supernatants, equal volumes of concentrated supernatants were used. Details are given in METHODS. in nonconfluent cultures. It was shown by Western blot analysis that COX-2 protein expression was induced in only nonconfluent cultures, whereas there was often little to no change in COX-1 expression between the two culture conditions. Similar results were observed in mouse epidermis after in vivo mechanical injury (64) , in which the induction of COX-2 expression was time dependent. Also, regulation of COX-2 gene expression, at the transcriptional (71) and posttranscriptional levels (20, 63) , can influence the COX-2 protein expression; however, these regulatory pathways have not been well examined in human keratinocytes.
The fact that the level of COX-1 expression varied between individuals was of interest because it may be related to the level of COX-2 induction. This observation was consistent with a recent report examining the compensatory PGE 2 biosynthesis in lung fibroblast cells from COX-1-or COX-2-deficient mice in which the expression of remaining functional COX gene was upregulated to compensate for the lack of the other isoform (30) . Therefore, additional studies of the difference in the ratio of COX-1 to inducible COX-2 between individuals are required to assess its role in individual variability in wound healing.
Second, we found that basal AA release was elevated in nonconfluent cultures compared with confluent conditions (Table 1) . Thus there is more substrate available for COX enzyme metabolism in nonconfluent conditions. The finding that basal LA levels are also higher in nonconfluent cultures indicated that nonsubstrate-specific PLA 2 activity is elevated in nonconfluent keratinocyte cultures. Although increased LA release has little influence on PGE 2 biosynthesis in nonconfluent cultures, LA plays a direct role for establishment and maintenance of the epidermal permeability barrier (17) . In addition, a 15-lipoxygenase product of LA, 13-hydroxyoctadecadienoic acid, has a potentiating effect on epidermal growth factor-dependent mitogenesis in rodent fibroblasts (18) . Also, 12-hydroxyeicosatetraenoic acid, a 12-lipoxygenase product of AA, has stimulatory effects including activation of protein kinase C and cell motility in tumor cells (26, 40) . Together, these reports suggest that linoleic and arachidonic lipoxygenase metabolites may also be important in the migration and/or proliferation of keratinocytes during wound healing. One microgram of total RNA obtained from confluent and nonconfluent human primary keratinocyte cultures was used for each RT-PCR reaction. As positive controls, amplifications were performed using 1 µg of total RNA from 2 HEK-293 cell lines, RAS2FB and H101D, which overexpressed type IIA sPLA 2 and type V sPLA 2 , respectively. RT-PCR was performed as described in METHODS. Amplifications using no template and RT reactions using all RNA conditions without RT (data not shown) were included as negative controls. Fragment sizes of ϳ449 and ϳ280 bp (major PCR product) obtained were consistent with predicted sizes of type IIA sPLA 2 (A) and type V sPLA 2 (B) cDNA fragments. An additional fragment at ϳ380 bp (minor PCR product) was detected in type V sPLA 2 (B) amplifications. Confirmation of identity of these fragments was done by sequencing as described in METHODS and discussed in text. Fig. 7 . Expression of M-type sPLA 2 receptor in human nonconfluent and confluent primary cultures as assessed by RT-PCR. Identical amounts of total RNA and negative controls as mentioned in Fig. 6 were used. Fragment size of ϳ399 bp detected was consistent with predicted size of type M-sPLA 2 receptor cDNA fragments. Confirmation of identify of this fragment was also done by sequencing.
In an examination of cPLA 2 and sPLA 2 protein expression in confluent and nonconfluent keratinocyte cultures, we found that cPLA 2 levels, although low, were unchanged. In contrast, there was an increase in sPLA 2 (type IIA and/or type V) protein levels in nonconfluent conditions. We observed that most of the sPLA 2 protein was cell-associated rather than secreted, although a small amount was detected in supernatants from nonconfluent conditions. This is consistent with other reports in which membrane-associated sPLA 2 was the predominant form in other cell types (49, 66) . Therefore, upregulation of sPLA 2 protein expression in coordination with induction of COX-2 expression appears to be the dominant pathway by which keratinocytes increase PGE 2 production in nonconfluent cultures.
Despite the clear coordinate induction of sPLA 2 and COX-2, increased activation of cPLA 2 may also contribute to elevated AA release. Studies in human astrocytes (24) and rat mesangial cells (27) show that type IIA-sPLA 2 caused posttranslational modification of cPLA 2 , probably through either a sPLA 2 receptor-mediated process (24) or production of lipid metabolites (27) . Finally, indirect production of AA by phospholipase C and/or D pathways may also be involved because both phospholipases are present in human keratinocytes and are activated by UV damage (11). However, AA release studies using bovine endothelial cells found no changes in phospholipase C activity from the progression of cells from the nonconfluent to confluent state (70).
Andersen et al. (2) reported that a nonpancreatic type II sPLA 2 mRNA transcript and protein is present in human epidermis, with low amounts found in normal epidermis and increased levels in involved skin from patients with psoriasis. Recently, Li-Stiles et al. (36) identified a type IIA sPLA 2 in mouse keratinocytes by RT-PCR, but the presence of type V sPLA 2 was not evaluated. We found that both type IIA and type V sPLA 2 messages were expressed in human keratinocytes. Expression of both sPLA 2 transcripts appeared to be very low. Given the low abundance of messages, a more quantitative measure of differences in mRNA expression levels by Northern blot analysis was not attempted. Reports indicated that it is type V sPLA 2 , not type IIA sPLA 2 , that is involved in the AA mobilization and PGE 2 production triggered by inflammatory stimuli (4, 62) . To determine whether one of these sPLA 2 s is selectively responsible for increased fatty acid release observed in nonconfluent culture conditions is currently being investigated. Recently, Murakami et al. (50) demonstrated that these sPLA 2 s are functionally redundant in terms of AA release and membrane binding using overexpressing cell lines. Therefore, specific preference for different fatty acid pools, the localization of action, and modes of regulation involved may be the important determinants for distinguishing the function of various sPLA 2 s expressed in a cell or tissue. This needs to be further elucidated by using in vivo models.
We also identified that message for an M-type sPLA 2 receptor was expressed in both nonconfluent and confluent primary keratinocyte cultures. The presence of the sPLA 2 receptor may be of particular importance to the mechanism of keratinocyte activation because the receptor has been shown to mediate cell proliferation and chemotactic cell migration, as well as endotoxic shock and eicosanoid biosynthesis in other cell types (24, 48, 53, 66) . The 180-kDa M-type sPLA 2 receptor, originally identified in rabbit skeletal muscle (35) , has been cloned and characterized from many sources (1, 25) . Previously, human sPLA 2 receptor has been found to be expressed in kidney, placenta, pancreas, lung, and skeletal muscle. However, a high-affinity ligand for the human receptor has not yet been identified; binding studies using recombinantly expressed human type IB and type IIA sPLA 2 have shown only low-affinity binding for a cloned human sPLA 2 receptor (15). Binding properties for type V and type X sPLA 2 s have yet to be reported. Studies showing rapid internalization of sPLA 2 on binding to its receptor suggest a possible regulatory role of the sPLA 2 receptor in the clearance of sPLA 2 from the extracellular environment (73) . In addition, sPLA 2 receptor may mediate cross talk between different PLA 2 s. For example, several studies found that exogenous addition of a type I sPLA 2 induced production and secretion of type IIA sPLA 2 on receptor binding and, in turn, increased PGE 2 production in rat mesangial cells (31, 47) . Another study showed activation of a mitogen-activated protein kinase cascade and cPLA 2 on addition of type IIA sPLA 2 (24) . The role of the sPLA 2 receptor in keratinocytes remains to be elucidated.
Several groups have reported that a functional coupling between sPLA 2 and COX-2 was responsible for the delayed, sustained prostaglandin synthesis on agonist stimulation in several cell types (5, 9, 34, 49, 51, 66) . The time course of PGE 2 production shown in our in vitro wounding experiments was strikingly similar to the time courses shown in the above-mentioned studies, indicating that functional coupling between COXs and PLA 2 may also occur during in vitro wounding. In human keratinocytes grown at nonconfluent cell densities, our results suggested that sPLA 2 and COX-2 are functionally coupled because both sPLA 2 and COX-2 protein expression were coinduced under these conditions. It is not clear what mediates the coordinated induction of sPLA 2 and COX-2 protein expression and what continually maintains their expression in nonconfluent cultures. Keratinocytes in nonconfluent conditions may be responding to the lack of neighboring cells and/or the mechanical stress induced by motility (54) . Mechanical stress has been shown to cause the upregulation of genes, including COX-2 in human vascular endothelial cells (69) .
In conclusion, nonconfluent primary keratinocyte cultures are a good model for studying keratinocyte activation because they appear to mimic functional and morphological characteristics observed during wound healing. Increased production of fatty acids and prostaglandins in nonconfluent keratinocytes appears to involve the coordinate induction of sPLA 2 s and COX-2 expression. With our identification of type V sPLA 2 and an M-type sPLA 2 receptor, another level of complexity
